<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<rss version="2.0">
<channel>
<title>AES New York 2018</title>
<link>https://aes.vporoom.com/</link>
<description></description>
<item>
<title>China's Tech Rising Star Zhongwei Sail Breaks Micro LED Barriers; First Solutions Set for Global Debut at AES in UAE</title>
<link>https://aes.vporoom.com/2025-12-16-Chinas-Tech-Rising-Star-Zhongwei-Sail-Breaks-Micro-LED-Barriers-First-Solutions-Set-for-Global-Debut-at-AES-in-UAE</link>
<description></description>
<pubDate>Tue, 16 Dec 2025 15:00:00 -0500</pubDate>
<guid>https://aes.vporoom.com/2025-12-16-Chinas-Tech-Rising-Star-Zhongwei-Sail-Breaks-Micro-LED-Barriers-First-Solutions-Set-for-Global-Debut-at-AES-in-UAE</guid>
</item>
<item>
<title>Biocodex To Present New Data at the American Epilepsy Society (AES) 2025 Annual Meeting</title>
<link>https://aes.vporoom.com/2025-12-01-Biocodex-To-Present-New-Data-at-the-American-Epilepsy-Society-AES-2025-Annual-Meeting</link>
<description></description>
<pubDate>Mon, 01 Dec 2025 09:00:00 -0500</pubDate>
<guid>https://aes.vporoom.com/2025-12-01-Biocodex-To-Present-New-Data-at-the-American-Epilepsy-Society-AES-2025-Annual-Meeting</guid>
<enclosure url="https://mma.prnewswire.com/media/2810610/Biocodex_DIACOMIT.jpg?p=thumbnail" type="image/jpeg" />
</item>
<item>
<title>SK Life Science, Inc. Presents XCOPRI® (cenobamate tablets) CV Data at the AES 2024 Annual Meeting Showing a Deeper Understanding of Cenobamate's Dual Mechanism of Action</title>
<link>https://aes.vporoom.com/2024-12-08-SK-Life-Science,-Inc-Presents-XCOPRI-R-cenobamate-tablets-CV-Data-at-the-AES-2024-Annual-Meeting-Showing-a-Deeper-Understanding-of-Cenobamates-Dual-Mechanism-of-Action</link>
<description></description>
<pubDate>Sun, 08 Dec 2024 15:00:00 -0500</pubDate>
<guid>https://aes.vporoom.com/2024-12-08-SK-Life-Science,-Inc-Presents-XCOPRI-R-cenobamate-tablets-CV-Data-at-the-AES-2024-Annual-Meeting-Showing-a-Deeper-Understanding-of-Cenobamates-Dual-Mechanism-of-Action</guid>
</item>
<item>
<title>Jazz Pharmaceuticals to Showcase New Real-World Evidence Reinforcing Epidiolex® (cannabidiol) Benefits and Broad-Spectrum Efficacy in Treatment-Resistant Epilepsies at the American Epilepsy Society 2024 Annual Meeting</title>
<link>https://aes.vporoom.com/2024-12-06-Jazz-Pharmaceuticals-to-Showcase-New-Real-World-Evidence-Reinforcing-Epidiolex-R-cannabidiol-Benefits-and-Broad-Spectrum-Efficacy-in-Treatment-Resistant-Epilepsies-at-the-American-Epilepsy-Society-2024-Annual-Meeting</link>
<description></description>
<pubDate>Fri, 06 Dec 2024 16:05:00 -0500</pubDate>
<guid>https://aes.vporoom.com/2024-12-06-Jazz-Pharmaceuticals-to-Showcase-New-Real-World-Evidence-Reinforcing-Epidiolex-R-cannabidiol-Benefits-and-Broad-Spectrum-Efficacy-in-Treatment-Resistant-Epilepsies-at-the-American-Epilepsy-Society-2024-Annual-Meeting</guid>
</item>
<item>
<title>New Preclinical Data Demonstrate Potential of Capsida's IV Gene Therapy for STXBP1-DEE to Correct all Disease Manifestations</title>
<link>https://aes.vporoom.com/2024-12-06-New-Preclinical-Data-Demonstrate-Potential-of-Capsidas-IV-Gene-Therapy-for-STXBP1-DEE-to-Correct-all-Disease-Manifestations</link>
<description></description>
<pubDate>Fri, 06 Dec 2024 12:00:00 -0500</pubDate>
<guid>https://aes.vporoom.com/2024-12-06-New-Preclinical-Data-Demonstrate-Potential-of-Capsidas-IV-Gene-Therapy-for-STXBP1-DEE-to-Correct-all-Disease-Manifestations</guid>
</item>
</channel>
</rss>
